Active ingredient-resistant malaria pathogens detected in Uganda

In order to at least mitigate a malaria infection, one drug in particular is used worldwide: artemisinin.

For years there have been reports from Asia about resistance to the drug. The fear was that such resistance could spread to Africa, where 90 percent of malaria cases are reported.

Im New England Journal of Medicine confirm Researchers from Uganda now have this fear. You have examined samples from malaria patients over a period of two years. Twenty percent of the samples showed mutations in the pathogen, which indicate that treatment with artemisinin is ineffective.

Several studies are currently looking for a vaccine against malaria, but the vaccines are all still in the test stage. Research therefore strongly recommends looking for alternative active ingredients.

Every year more than 220 million people become infected with the disease, which is transmitted by a mosquito. There are more than 400,000 deaths every year – most of them are children under 5.

This message was broadcast on September 24th, 2021 on Deutschlandfunk.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.